Background: Depression is one of the leading causes of disability around the globe. In the early years of depression, it is hypothesized that neurotransmitters have a major or dominant role in depression pathophysiology. The roles of different parts of the brain and neurotransmitters have emerged at different intervals of time, and various hypotheses beyond monoamines have arisen. In this review, numerous theories that have been proposed in the last 60 years are covered based on the literature. Methodology: This review was prepared with literature and data presented from different databases including PubMed, Frontier in Pharmacology, Elsevier, Journal of Depression and Anxiety, etc. Results: The different hypotheses of depression have been presented in different eras. Each hypothesis of depression tries to explore different aspects of depression, which shifts the pathogenesis of depression approaches towards bio-molecule and genetic roles. Conclusion: The pathophysiology of depression is very complex. None of the hypotheses alone can explain the pathophysiology of depression. All of these hypotheses are interconnected with each other. Through these hypotheses, it can be concluded that neuro-inflammation can be the base of depression and by reducing this factor we can overcome this problem
背景:抑郁症是全球范围内致残的主要原因之一。在抑郁症的早期,人们假设神经递质在抑郁症的病理生理中起主要或主导作用。大脑的不同部分和神经递质的作用在不同的时间间隔出现,除了单胺之外的各种假设也出现了。在这篇综述中,在文献的基础上,涵盖了过去60年来提出的许多理论。方法学:本综述采用来自PubMed、Frontier in Pharmacology、Elsevier、Journal of Depression and Anxiety等不同数据库的文献和数据。结果:不同时期出现了不同的抑郁假说。每一种假说都试图探索抑郁症的不同方面,从而将抑郁症的发病机制转向生物分子和遗传作用。结论:抑郁症的病理生理十分复杂。这些假说都不能单独解释抑郁症的病理生理学。所有这些假设都是相互联系的。通过这些假设,可以得出结论,神经炎症可能是抑郁症的基础,通过减少这一因素,我们可以克服这一问题
{"title":"Deciphering the Role of Various Signaling Pathways in the Pathophysiology of Depression","authors":"Etash Vashisht, Vishal Vats, Ravinder Verma, Jatin Parashar, Vandana Garg, Rohit Dutt, Vineet Mittal, Govind Singh, Deepak Kaushik","doi":"10.2174/0115743624255521230920070219","DOIUrl":"https://doi.org/10.2174/0115743624255521230920070219","url":null,"abstract":"Background: Depression is one of the leading causes of disability around the globe. In the early years of depression, it is hypothesized that neurotransmitters have a major or dominant role in depression pathophysiology. The roles of different parts of the brain and neurotransmitters have emerged at different intervals of time, and various hypotheses beyond monoamines have arisen. In this review, numerous theories that have been proposed in the last 60 years are covered based on the literature. Methodology: This review was prepared with literature and data presented from different databases including PubMed, Frontier in Pharmacology, Elsevier, Journal of Depression and Anxiety, etc. Results: The different hypotheses of depression have been presented in different eras. Each hypothesis of depression tries to explore different aspects of depression, which shifts the pathogenesis of depression approaches towards bio-molecule and genetic roles. Conclusion: The pathophysiology of depression is very complex. None of the hypotheses alone can explain the pathophysiology of depression. All of these hypotheses are interconnected with each other. Through these hypotheses, it can be concluded that neuro-inflammation can be the base of depression and by reducing this factor we can overcome this problem","PeriodicalId":10868,"journal":{"name":"Current Signal Transduction Therapy","volume":"4 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135546036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-08-17DOI: 10.2174/1574362418666230817100406
A. Verma, P. Wadhwa
RET (Rearranged during transcription) kinase is one of the key targets for anticancer drug development. Understanding the real mechanism of pharmacological action is aided by the protein-ligand interaction. The purpose of this study is to find the most effective RET inhibitors. Firstly, through a literature survey, we understood that tetrazole is useful nuclei to provide anticancer activity. Hence, a molecule was drawn containing tetrazole ring using Chemdraw 16.0. This drawn compound was used to determine further ligands employing Zincpharmer. Then, the 3D energy minimized structure of proposed ligands and positive control (selpercatinib and pralsetinib) were drawn using Chem3D. Further, docking was performed for all the ligands with phosphorylated RET kinase (PDB ID – 2IVU) using trial version of Molegro virtual docker 7.0. Determined ligands were docked with the help of Molegro virtual Docker (MVD) 7.0 employing RET kinase (2ivu) as protein. Top 10 compounds were selected and their drug-like properties along with their oral bioavailability were also determined. ZINC12180698, ZINC12180696, ZINC09616526, ZINC12180701, ZINC09616182, ZINC09616145, ZINC17052231, ZINC17052262, ZINC12180700, and ZINC09616518 were among the top ten compounds that showed the strongest affinity for the target for RET-mediated cancer in this study.
RET (rearrange during transcription)激酶是抗癌药物开发的关键靶点之一。了解药理学作用的真正机制有助于蛋白质与配体的相互作用。本研究的目的是寻找最有效的RET抑制剂。首先,通过文献综述,我们了解到四氮唑是提供抗癌活性的有用原子核。因此,使用Chemdraw 16.0绘制了含有四唑环的分子。该化合物被用来用锌法测定进一步的配体。然后,利用Chem3D绘制了拟配体和正对照(selpercatinib和pralsetinib)的三维能量最小化结构。此外,使用Molegro虚拟docker 7.0试用版对磷酸化RET激酶(PDB ID - 2IVU)的所有配体进行对接。以RET激酶(2ivu)为蛋白,利用Molegro virtual Docker (MVD) 7.0进行配体对接。筛选出10个最佳化合物,并测定其药物样性质及口服生物利用度。ZINC12180698、ZINC12180696、ZINC09616526、ZINC12180701、ZINC09616182、ZINC09616145、ZINC17052231、ZINC17052262、ZINC12180700和ZINC09616518是本研究中与ret介导的癌症靶点亲和力最强的前十位化合物。
{"title":"An Identification of RET inhibitor: A Computational Study","authors":"A. Verma, P. Wadhwa","doi":"10.2174/1574362418666230817100406","DOIUrl":"https://doi.org/10.2174/1574362418666230817100406","url":null,"abstract":"\u0000\u0000RET (Rearranged during transcription) kinase is one of the key targets for anticancer drug development. Understanding the real mechanism of pharmacological action is aided by the protein-ligand interaction. The purpose of this study is to find the most effective RET inhibitors.\u0000\u0000\u0000\u0000Firstly, through a literature survey, we understood that tetrazole is useful nuclei to provide anticancer activity. Hence, a molecule was drawn containing tetrazole ring using Chemdraw 16.0. This drawn compound was used to determine further ligands employing Zincpharmer. Then, the 3D energy minimized structure of proposed ligands and positive control (selpercatinib and pralsetinib) were drawn using Chem3D. Further, docking was performed for all the ligands with phosphorylated RET kinase (PDB ID – 2IVU) using trial version of Molegro virtual docker 7.0.\u0000\u0000\u0000\u0000Determined ligands were docked with the help of Molegro virtual Docker (MVD) 7.0 employing RET kinase (2ivu) as protein.\u0000\u0000\u0000\u0000Top 10 compounds were selected and their drug-like properties along with their oral bioavailability were also determined. ZINC12180698, ZINC12180696, ZINC09616526, ZINC12180701, ZINC09616182, ZINC09616145, ZINC17052231, ZINC17052262, ZINC12180700, and ZINC09616518 were among the top ten compounds that showed the strongest affinity for the target for RET-mediated cancer in this study.\u0000","PeriodicalId":10868,"journal":{"name":"Current Signal Transduction Therapy","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41780607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-08-10DOI: 10.2174/1574362418666230810094626
A. Ali, Alwisha Lateef, Zuha Waheed, Mishal Waseem, Tahreem Zaheer, Miriam K Gomez, R. Blaheta, Saira Justin
Bladder cancer is the 9th most prevalent malignancy worldwide. Fibroblast Growth Factor Receptor 3b (FGFR3b), involved in cell proliferation, differentiation, and migration, is a mutations hotspot for bladder cancer with the most prevalent aberration being S249C. Impact of S249C of FGFR3b on bladder tumorigenesis via immediate downstream adapter proteins, Fibroblast Growth Factor Receptor Substrate (FRS2 and FRS3) is analyzed computationally. Wildtype FGFR3b monomer was modeled using I-TASSER and Phyre2. Whereas, S249C mutation was introduced via DynaMut. Wildtype FGFR3b homodimer and mutant heterodimer were structured and docked with downstream proteins using HADDOCK. PDBSum was used to study the amino acid residues involved in intermolecular and intramolecular interactions. Parameters of molecular flexibility and interatomic interactions predicted S249C heterodimer mutation of FGFR3b to be stable. Furthermore, docking with FRS2 protein revealed greater stability and higher binding affinity for S249C heterodimer mutant compared to wildtype homodimer. However, FRS3 docking showed a negligible decline in binding affinity for the S249C mutation but based on Van der Waal’s energy and insights into the interacting residues, it was revealed that these interactions might be stronger and for longer duration in comparison to the wildtype homodimer. S249C heterodimer mutation of FGFR3b is predicted to be stable with a tumorigenic potential where FRS2 and FRS3 might be among the key players of altered downstream signaling. Further investigations are required for a detailed picture.
膀胱癌是全球第九大恶性肿瘤。成纤维细胞生长因子受体3b (FibroblastGrowth Factor Receptor 3b, FGFR3b)参与细胞增殖、分化和迁移,是膀胱癌的突变热点,最常见的畸变是S249C。计算分析了FGFR3b的S249C通过直接下游适配器蛋白,成纤维细胞生长因子受体底物(FRS2和FRS3)对膀胱肿瘤发生的影响。使用I-TASSER和Phyre2对野生型FGFR3b单体进行建模。而S249C突变是通过DynaMut引入的。利用HADDOCK构建野生型FGFR3b同型二聚体和突变型异源二聚体,并与下游蛋白对接。PDBSum用于研究参与分子间和分子内相互作用的氨基酸残基。分子柔韧性和原子间相互作用参数预测FGFR3b的S249C异源二聚体突变是稳定的。此外,与FRS2蛋白对接表明,与野生型同型二聚体相比,S249C异源二聚体突变体具有更高的稳定性和结合亲和力。然而,FRS3对接显示对S249C突变的结合亲和力可以忽略不计,但基于Van der Waal能量和对相互作用残基的了解,揭示了与野生型同型二聚体相比,这些相互作用可能更强,持续时间更长。FGFR3b的S249C异源二聚体突变被预测为稳定的,具有致瘤潜力,其中FRS2和FRS3可能是下游信号改变的关键参与者之一。需要进一步调查才能获得详细的情况。
{"title":"Mutation S249C of FGFR3b Promotes Bladder Cancer through Downstream\u0000Signaling Proteins FRS2 and FRS3: A Computational Approach","authors":"A. Ali, Alwisha Lateef, Zuha Waheed, Mishal Waseem, Tahreem Zaheer, Miriam K Gomez, R. Blaheta, Saira Justin","doi":"10.2174/1574362418666230810094626","DOIUrl":"https://doi.org/10.2174/1574362418666230810094626","url":null,"abstract":"\u0000\u0000Bladder cancer is the 9th most prevalent malignancy worldwide. Fibroblast\u0000Growth Factor Receptor 3b (FGFR3b), involved in cell proliferation, differentiation, and migration,\u0000is a mutations hotspot for bladder cancer with the most prevalent aberration being S249C.\u0000\u0000\u0000\u0000Impact of S249C of FGFR3b on bladder tumorigenesis via immediate downstream adapter\u0000proteins, Fibroblast Growth Factor Receptor Substrate (FRS2 and FRS3) is analyzed computationally.\u0000\u0000\u0000\u0000Wildtype FGFR3b monomer was modeled using I-TASSER and Phyre2. Whereas,\u0000S249C mutation was introduced via DynaMut. Wildtype FGFR3b homodimer and mutant heterodimer were structured and docked with downstream proteins using HADDOCK. PDBSum was\u0000used to study the amino acid residues involved in intermolecular and intramolecular interactions.\u0000\u0000\u0000\u0000Parameters of molecular flexibility and interatomic interactions predicted S249C heterodimer mutation of FGFR3b to be stable. Furthermore, docking with FRS2 protein revealed greater\u0000stability and higher binding affinity for S249C heterodimer mutant compared to wildtype homodimer. However, FRS3 docking showed a negligible decline in binding affinity for the S249C mutation but based on Van der Waal’s energy and insights into the interacting residues, it was revealed\u0000that these interactions might be stronger and for longer duration in comparison to the wildtype homodimer.\u0000\u0000\u0000\u0000S249C heterodimer mutation of FGFR3b is predicted to be stable with a tumorigenic\u0000potential where FRS2 and FRS3 might be among the key players of altered downstream signaling.\u0000Further investigations are required for a detailed picture.\u0000","PeriodicalId":10868,"journal":{"name":"Current Signal Transduction Therapy","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42422047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}